|

Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells Clinical Trials

1 actively recruiting trial

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Indications

Other1 trial

A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.